Cite
HARVARD Citation
Hu, J. et al. (2019). Enhancer of zeste 2 polycomb repressive complex 2 subunit promotes sorafenib resistance of hepatocellular carcinoma though insulin-like growth factor 1 receptor. Anti-cancer drugs. 30 (7), p. . [Online].